NeuroLogica unveiled a mobile multislice CT system, CereTom, at the RSNA meeting. The 20-month-old company designed the device for head and neck imaging of patients suspected of traumatic brain injury.
NeuroLogica unveiled a mobile multislice CT system, CereTom, at the RSNA meeting. The 20-month-old company designed the device for head and neck imaging of patients suspected of traumatic brain injury.
The compact eight-slice scanner features a 25-cm field-of-view which produces spatial resolution on par with leading high-end CT scanners, according to the company. The unit is self-contained, is equipped with a head board that can be slid under the patient, and includes a built-in translation mechanism that moves back and forth over the head. This eliminates the 8- to 10-foot patient table that commonly accompanies CTs.
Because it is compact, just under four feet high by 29 inches wide, and sits on casters, CereTom can be wheeled anywhere in a hospital, such as to the emergency department or intensive care unit. Because the device does not require x-ray shielding, it may be suitable for dental and maxillofacial surgery offices. It could even be mounted in an ambulance.
Utilizing a wireless image transfer system, CereTom processes images wherever a patient is located. Images are transmitted to a laptop workstation that incorporates advanced software tools, including 3D CT viewing packages from Voxar. The battery-driven unit can scan up to eight patients without recharging, or it can draw power from a standard electrical outlet.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.